Philadelphia, PENNSYLVANIA4 Active Studies

Head and Neck Cancer Clinical Trials in Philadelphia, PENNSYLVANIA

Find 4 actively recruiting head and neck cancer clinical trials in Philadelphia, PENNSYLVANIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
882
Enrolling

Recruiting Head and Neck Cancer Studies in Philadelphia

RecruitingPhiladelphia, PENNSYLVANIANCT06699212

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy (PIT) in combination with pembrolizumab works to treat recurrent squamous cell cancer of the head and neck (HNSCC) with no di...

412 participants
Rakuten Medical, Inc.
View Study Details
RecruitingPhiladelphia, PENNSYLVANIANCT06790966

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

This is a global, multi-center, Phase 3 study that is randomized 2:1, controlled, and open label to evaluate PDS0101 (Versamune + HPVMix) in combination with pembrolizumab vs. pembrolizumab monotherap...

351 participants
PDS Biotechnology Corp.
View Study Details
RecruitingPhiladelphia, PENNSYLVANIANCT05714657

Shortened Course Adjuvant Radiotherapy Following TORS

This is a single-arm, phase II study to establish the safety of reducing radiation dose in selected HPV-Associated OPSCC patients receiving adjuvant radiation after TORS and neck dissection. This prot...

104 participants
Abramson Cancer Center at Penn Medicine
View Study Details
RecruitingPhiladelphia, PENNSYLVANIANCT05977907

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

This research is being done to see if it is safe to give investigational combination of study drugs (Pembrolizumab and IO102-103) before surgery to people with surgically resectable (removable) newly ...

15 participants
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
View Study Details

About Head and Neck Cancer Clinical Trials in Philadelphia

Head and neck cancers develop in the mouth, throat, larynx, sinuses, or salivary glands. HPV-related oropharyngeal cancers have been increasing in prevalence. Treatment includes surgery, radiation, chemotherapy, and immunotherapy.

There are currently 4 head and neck cancer clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 882 participants. Research is being sponsored by Rakuten Medical, Inc., PDS Biotechnology Corp., Abramson Cancer Center at Penn Medicine and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Head and Neck Cancer Clinical Trials in Philadelphia — FAQ

Are there head and neck cancer clinical trials in Philadelphia?

Yes, there are 4 head and neck cancer clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What head and neck cancer treatments are being tested?

The 4 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for head and neck cancer.

Data updated March 2, 2026 from ClinicalTrials.gov